Your search returned 4 results.

Results
	1.	Onartuzumab with or without bevacizumab in combination with weekly paclitaxel does not prolong QTc or adversely affect other ECG parameters in patients with locally recurrent or metastatic triple-negative breast cancer. [electronic resource] by Borin, Marie T Chen, Meng Mocci, Simonetta Rubets, Igor Chittenden, Jason Aldairy, Wassim Stroh, Mark Producer: 20150331 In: Cancer chemotherapy and pharmacology vol. 75 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Population pharmacokinetic and exposure-response analysis of eptinezumab in the treatment of episodic and chronic migraine. [electronic resource] by Baker, Brian Schaeffler, Barbara Beliveau, Martin Rubets, Igor Pederson, Susan Trinh, MyMy Smith, Jeff Latham, John Producer: 20210402 In: Pharmacology research & perspectives vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Pharmacokinetics and safety of neratinib during co-administration with loperamide in healthy subjects. [electronic resource] by Keyvanjah, Kiana Cooke, Blaire Martin, David Di Primeo, Daniel Sterling, Laura Liang, Jane Olek, Elizabeth Rubets, Igor Wong, Alvin Producer: 20200519 In: Cancer chemotherapy and pharmacology vol. 84 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Pharmacokinetics of amlodipine and olmesartan after administration of amlodipine besylate and olmesartan medoxomil in separate dosage forms and as a fixed-dose combination. [electronic resource] by Rohatagi, Shashank Lee, James Shenouda, Magdy Haworth, Stephen Bathala, Mohinder Singh Allison, Mark Rubets, Igor Heyrman, Reinilde Noveck, Robert Salazar, Daniel E Producer: 20081216 In: Journal of clinical pharmacology vol. 48 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)